The U.S. Department of Justice has expanded an antitrust investigation to include UnitedHealth Group's Claritev unit. The Claritev review is part of broader DOJ scrutiny of healthcare industry practices and market competition. This development adds a fresh layer of regulatory attention for UnitedHealth Group (NYSE:UNH) beyond routine oversight. UnitedHealth Group, one of the largest managed care and healthcare services companies in the U.S., spans insurance, care delivery, and data-driven...
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
527last 24h
2509last 7d
482● bullish (7d)
257● bearish (7d)
197publishers
Simply Wall St.21d agobearish
UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review ExpandsMT Newswires21d agobearish
Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se
MT Newswires21d agobearish
Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev(Update with the Justice Department's response to a request for comment in the third paragraph.)
Healthcare Dive35d agobearish
Court dismisses PBMs’ lawsuit against FTC following insulin settlementsExpress Scripts, Caremark and Optum Rx sued the FTC after the agency accused them of driving up the cost of insulin. But the countersuit is being put to bed now that the PBMs are settling with regulators.